Ozanimod (RPC1063), a selective S1P_R1 and S1P_R5 modulator, reduces chronic inflammation and alleviates kidney pathology in murine systemic lupus erythematosus

• Kristen R. Taylor Meadows ,

  Roles Conceptualization, Formal analysis, Investigation, Methodology, Project administration, Supervision, Visualization, Writing – original draft, Writing – review & editing

  * E-mail: krtaylor@celgene.com

  Affiliation Receptos, a wholly owned subsidiary of Celgene Corporation, San Diego, California, United States of America

  ⨯
• Marcos W. Steinberg,

  Roles Conceptualization, Formal analysis, Investigation, Methodology, Supervision, Visualization, Writing – original draft, Writing – review & editing

  Affiliation Receptos, a wholly owned subsidiary of Celgene Corporation, San Diego, California, United States of America

  ⨯
• Bryan Clemons,

  Roles Conceptualization, Formal analysis, Investigation, Methodology, Writing – review & editing

  Affiliation Receptos, a wholly owned subsidiary of Celgene Corporation, San Diego, California, United States of America

  ⨯
• Matthew E. Stokes,

  Roles Formal analysis, Writing – review & editing

  Affiliation Celgene Corporation, Seattle, Washington, United States of America

  ⨯
• Gregory J. Opiteck,

  Roles Conceptualization, Supervision, Writing – original draft, Writing – review & editing

  Affiliation Receptos, a wholly owned subsidiary of Celgene Corporation, San Diego, California, United States of America

  ⨯
• Robert Peach,

  Roles Conceptualization, Supervision, Writing – review & editing

  Affiliation Receptos, a wholly owned subsidiary of Celgene Corporation, San Diego, California, United States of America

  ⨯
• Fiona L. Scott

  Roles Conceptualization, Formal analysis, Funding acquisition, Methodology, Project administration, Supervision, Visualization, Writing – original draft, Writing – review & editing

  Affiliation Receptos, a wholly owned subsidiary of Celgene Corporation, San Diego, California, United States of America

  ⨯